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1. Introduction 
The metabolic activation of the polycyclic hydro- 
carbons benzo [a] pyrene and 7-methylbenz [a] anthra- 
cene in mouse skin appears to involve the forma- 
tion of vicinal diol-epoxides [l] that react with nucleic 
acids in this tissue [2-51. This mechanism of activa- 
tion may be a general one for this class of chemical 
carcinogens and efforts are now being made to extend 
the hypothesis to include other hydrocarbons. The 
examination, using photon-counting spectrofluorim- 
etry, of nucleic acids isolated from tis’sues treated 
in vivo with polycyclic hydrocarbons, has already 
proved to be of value in identifying the sites of activa- 
tion in benzo [a] pyrene [2] and in 7-methylbenz [a] 
anthracene [4,6] . In this paper we present data from 
fluorescence studies obtained with the potent car- 
cinogens 3-methylcholanthrene (I) and 7,12-dimethyl- 
benz[a] anthracene (II). These data show that the 
hydrocarbon moieties, bound to the DNA of mouse 
skin treated in vivo with either of the parent hydro- 
carbons, have spectral characteristics consistent with 
the retention of a substituted anthracene nucleus in 
*To whom correspondence should be addressed 
the covalently-bound adducts. If, as we suggest, 
vicinal dial-epoxide formation is involved in the 
activation process, then the present results indicate 
that in mouse skin this activation takes place in the 
7,8,9,10-ring of 3-methylcholanthrene and in the 
1,2,3,4-ring of 7,12-dimethylbenz[a] anthracene. 
2. Materials and methods 
2.1. A4aterials 
3-Methylcholanthrene, benz[a] anthracene and 
7,12-dimethylbenz[a] anthracene, purified by 
column chromatography and crystallization, and DNA 
(salmon sperm, type III) deproteinized by a detergent- 
salt procedure [7], were purchased (Sigma Chemical 
Co. St. Louis, MO). 7-Methylbenz[a] anthracene was 
prepared as described [8] . 
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2.2. Reactions with DNA 
Mouse skin DNA was isolated 24 h after shaved 
dorsal areas of the skin of male CS7Bl mice had been 
treated either with acetone (0.15 ml) or with an 
acetone solution (0.15 ml) of 3-methylcholanthrene 
(1 PM) or of 7,12-dimethylbenz [a] anthracene (1 FM) 
and was purified [2]. Other DNA samples, reacted 
with vicinal diol-epoxides derived from 7-methyl- 
benz [a] anthracene, were prepared exactly as described 
previously [4] . 
2.3. Fluorescence and absorbance spectra 
Fluorescence spectra were determined using the 
photon-counting spectrophotofluorimeter described 
[9] . All purified DNA preparations intended for 
fluorescence studies were dissolved in Tris-NaCl 
buffer (0.1 M, pH 7.5) prepared from water distilled 
from KMn04, then from Ba(OH)s and stored in a .’ 
silica container. Particulate matter, which interferes 
with low-level fluorescence measurements, was 
removed from DNA solutions by centrifugation 
immediately prior to fluorimetry. Excitation spectra 
were recorded using excitation and emission wave- 
length bandwidths of 6 nm and 3 nm, respectively. 
They were corrected for errors, in the response of the 
instrument’s excitation path, with data obtained from 
a sample of Rhodamine B used as a quantum counter. 
Emission spectra were recorded using excitation and 
emission wavelength bandwidths of 4.2 nm and 6.4 nm, 
respectively; they were not corrected for errors in the 
response of the instrument’s emission path since the 
correction factor was found to be negligible for the 
relevant wavelengths. Absorbance spectra of the hydro- 
carbons were recorded in ethanol using a Cary Model 
115 recording spectrophotometer. 
3. Results and discussion 
The fluorescence spectra characteristics of DNA 
isolated from mouse skin, treated in vivo with 
3-methylcholanthrene or with 7,12-dimethylbenz[a] - 
anthracene, were determined and compared both to 
those of DNA isolated from mouse skin, treated with 
7-methylbenz[a]anthracene, and to those of DNA 
reacted with related vicinal diol-epoxides. In addition, 
the shifts in the maxima present in these different 
fluorescence spectra were measured and compared to 
the shifts that were present in the absorbance and 
fluorescence spectra of the parent hydrocarbons 
benz [alanthracene, 7-methylbenz [a] anthracene, 
3-methylcholanthrene and 7,12-dimethylbenz[a] -
anthracene. 
Figure 1 shows the fluorescence spectra, recorded 
using the photon-counting spectrophotofluorimeter, 
for DNA isolated from mouse skin treated with 
3-methylcholanthrene and with 7,12-dimethylbenz[a] - 
anthracene, compared, in each case, with that of DNA 
isolated from mouse skin treated with acetone 
alone. From this type of data, difference spectra like 
those shown in fig.2 were prepared. The fluorescence 
emission spectra (fig.2B) obtained for DNA isolated 
from 3-methylcholanthrene-treated and from 7,12- 
dimethylbenz[a] anthracene-treated mouse skin 
resemble that of DNA isolated from 7-methylbenz [a] - 
Fig. 1. Fluorescence emission spectra shown by DNA isolated 
from mouse skin following treatment (0 l l l 0) with (A) 
3-methylcholanthrene and (B) 7,12dimethylbenz[ a] anthracene 
or treatment with acetone alone (o o o o o). DNA solutions 
had A 260 nm 12 and spectra were recorded at room temperature 
as described in the text using an excitation wavelength of 
302.5 nm. 
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Fig.2. Fluorescence excitation (A) and fluorescence mission 
(B) spectra shown by DNA isolated from mouse skin following 
treatment with 3-methylcholanthrene (- - -- - -) and 
7,12dimethylbenz[a]anthracene (-.-.-.-.-.) and those of 
DNA reacted with 3,4dihydro-3,4dihydroxy-7-methylbenz 
[a] anthracene 1,2-oxide (. . . .). The spectra are difference 
spectra normalized on their maxima. 
anthracene-treated mouse skin but with shifts in the 
maxima in both cases to longer wavelengths. 
The second important point is that these spectra 
(table 1) resemble, again with shifts to longer wave- 
lengths, the anthracene-like spectrum obtained from 
DNA following reaction with the 3,4-diol 1,2-oxide 
derived from 7-methylbenz [a] anthracene but do not 
resemble the phenanthrene type of spectrum obtained 
from DNA following reaction with the 8,9-diol 
IO,1 l-oxide derived from this hydrocarbon [4] . 
The progressive fluorescence spectral shifts encoun- 
tered with mouse-skin DNA samples carrying 7-methyl- 
benz[a] anthracene, 3-methylcholanthrene and 
7,12_dimethylbenz [a] anthracene moieties, respectively 
Table 1 
Fluorescence spectral properties of DNA isolated from mouse skin treated with 
3-methylcholanthrene or 7,12dimethylbenz[aJ anthracene or reacted with 
related model compoundsa 
DNA, modified in vivo by 
3-methylcholanthrene 
Excitatron maxima 
(nm) 
370,395 
Emission maxima 
(nm) 
432 
DNA, modified in vivo by 
7,12dimethyl- 
benz[a] anthracene 
(370), 392, (410) 450 
DNA, reacted with 
3,4dihydro-3,4dihydroxy- 
7-methylbenz[a] 
anthracene 1,2-oxide 
356,375,393 (400), 422, (445) 
DNA, reacted with 
8,9dihydro-8,9dihydroxy- 
7-methylbenz[a] 
anthracene IO,ll-oxide 
270,306 356, 373, (390), (416) 
aSpectra were measured in buffer as described in the text 
Values for shoulders in the spectra are given in parentheses 
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Fig.3. Absorption (A) and fluorescence emission (B) spectra 
recorded for benz[a] anthracene ( ), 7-methyl- 
benz[a]anthracene (. . . . . . .), 3-methylcholanthrene 
(- - - - -) and 7,12dimethylbenz[a]anthracene 
(-.-.-.-.-.) showing the continuous red shift in relation to 
benz[a] anthracene within the series. 
(fig.2B) reflect the increasing shifts to longer wave- 
lengths present in the absorbance and fluorescence 
spectra of the hydrocarbons in the series benz[a] anthra- 
cene, 7-methylbenz [a] anthracene, 3-methylcholan- 
threne and 7,12-dimethylbenz [a] anthracene (fig.3) 
and this is consistent with the idea that a common 
mechanism of activation is applied to these hydro- 
carbons in mouse skin. With 7-methylbenz [a] anthra- 
cene, this mechanism is now thought to involve activa- 
tion in the 1,2,3,4-ring to yield the vicinal diol- 
epoxide, 3,4-dihydro-3,4-dihydroxy-7-methylbenz [a] - 
anthracene 1,2-oxide [4,5] and in systems where 
further metabolism can occur, the 3,4dihydrodiol 
has been found to be the most biologically-active 
diol tested in terms of mutagenicity [ lo,1 l] and 
carcinogenicity [ 11,121 .
If vicinal diolepoxides are involved in reactions 
with DNA in mouse skin treated with 3-methyl- 
cholanthrene or with 7,12-dimethylbenz [a] anthracene 
then the fluorescence spectral data presented here 
would appear to rule out activation involving the 3,4 
and 5 positions of 3-methylcholanthrene and the 
8,9,10 and 11 positions of 7,12-dimethylbenz[a] -
anthracene. They would however be quite consistent 
with metabolic activation giving rise to diol-epoxides 
in the 7,8,9,10-ring of 3-methylcholanthrene and in 
the 1,2,3,4-ring of 7,12-dimethylbenz [a] anthracene 
but much additional work is obviously required to 
provide a rigorous proof that this in fact occurs, since 
the spectral data alone may not exclude the presence 
of a fully aromatic ring system bound to DNA. 
With 7,12-dimethylbenz [a] anthracene, the fluor- 
escence data and the conclusions reported here for 
mouse skin are in good agreement with those obtained 
from mouse embryo cells in the recent studies of 
Moschel et al. [ 131 and with those of other workers 
who used hamster embryo cells (Geacintov, N. E. and 
Weinstein, I. B., personal communication). 
The case for metabolic activation that involves a 
diol-epoxide formed on the 1,2,3,4-ring of 
7,12-dimethylbenz[a] anthracene is much stronger 
than that which exists at present for the 7,8,9,10-ring 
of 3-methylcholanthrene for, in addition to the fluor- 
escence data obtained in different laboratories, 
7,12-dimethylbenz [a] anthracene is known to be 
metabolized by hydroxylation in the 1,2,3,4-ring 
[ 14,151 and nucleic acid products are thought not to 
arise through K-region activation [ 161 . The metab- 
olism of 3-methylcholanthrene and the nature of any 
nucleic acid adducts formed in vivo have not been 
examined in detail so far. 
The suggested mechanism of metabolic activation 
of 3-methylcholanthrene and 7,12-dimethylbenz [a] - 
anthracene involving vicinal diol-epoxides formed on 
the 7,8,9,10- and 1,2,3,4-rings, respectively, is in agree- 
ment both with our general hypothesis that vicinal 
diolepoxides are important in the metabolic activa- 
tion of the polycyclic hydrocarbons and with the more 
specialized hypothesis [ 171 which suggests, from 
quantum mechanical considerations, that diol-epoxides 
of the type exemplified by benzo [a] pyrene 7,8-diol 
9,10-oxide and by 7-methylbenz[a] anthracene 3,4-diol 
1,2-oxide might be expected to be particularly reactive 
compounds. 
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